Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
My PhD thesis work integrates bioinformatics/multi-omic data approaches with tools like CRISPR/Cas9-based gene editing to study chemotherapy resistance mechanisms in cancer.
In my work as a Venture Fellow at CU Innovations, I oversee a state-funded micro-grant program called Startup Toolbox to support entrepreneurs in the CU network to reach their commercialization milestones.
I graduated summa cum laude from the University of New Mexico with a B.S. in Biochemistry, minors in Chinese, Psychology, in May 2020.
PLATINUM SPONSORS:
SPONSORS: